The global hemodynamic monitoring market size reached US$ 1.15 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 1.68 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2023-2032.
Hemodynamic monitoring refers to the process of measuring the blood flow and pressure exerted in the heart, veins and arteries. It enables the assessment and optimization of hemodynamic parameters and oxygen delivery, which helps in diagnosing and treating various cardiopulmonary conditions and improving outcomes in critically ill patients. Over the years, hemodynamic monitoring has evolved from basic tracking of cardiac output (CO) to advanced devices that provide information about a wide array of variables, like blood pressure, blood volume and fluid balance.
Over the years, there has been a rise in the number of people suffering from cardiac dysfunction, which results in hemodynamic instability, thus ultimately leading to organ failure. Consequently, the demand for hemodynamic monitoring has significantly increased across the globe. In line with this, the introduction of more innovative, uncalibrated and non-invasive CO measurements obtained through the analysis of a non-invasive arterial pressure waveform is also contributing to the market growth. Furthermore, hemodynamic monitoring is being increasingly used across the healthcare sector to improve patient outcome and combat tissue hypoxia, shock and multiorgan failure in critically ill patients. Extensive research and development (R&D) activities act as another major growth-inducing factor. Manufacturers are undertaking initiatives for the development of simpler minimally- and non-invasive hemodynamic monitoring systems at affordable prices, which will offer more precise results. Other factors, rising healthcare expenditure by both government and private sectors and technological advancements, are further expected to create a positive outlook for the market in the coming years.
Monitors
Others
Minimally Invasive Monitoring
Noninvasive Monitoring
Clinics and Ambulatory Care Centers
Home Care Settings
Others
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
What are the key regional markets?
What has been the impact of COVID-19 on the global hemodynamic monitoring market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the monitoring?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hemodynamic monitoring industry and who are the key players?
What is the degree of competition in the industry?
Hemodynamic monitoring refers to the process of measuring the blood flow and pressure exerted in the heart, veins and arteries. It enables the assessment and optimization of hemodynamic parameters and oxygen delivery, which helps in diagnosing and treating various cardiopulmonary conditions and improving outcomes in critically ill patients. Over the years, hemodynamic monitoring has evolved from basic tracking of cardiac output (CO) to advanced devices that provide information about a wide array of variables, like blood pressure, blood volume and fluid balance.
Over the years, there has been a rise in the number of people suffering from cardiac dysfunction, which results in hemodynamic instability, thus ultimately leading to organ failure. Consequently, the demand for hemodynamic monitoring has significantly increased across the globe. In line with this, the introduction of more innovative, uncalibrated and non-invasive CO measurements obtained through the analysis of a non-invasive arterial pressure waveform is also contributing to the market growth. Furthermore, hemodynamic monitoring is being increasingly used across the healthcare sector to improve patient outcome and combat tissue hypoxia, shock and multiorgan failure in critically ill patients. Extensive research and development (R&D) activities act as another major growth-inducing factor. Manufacturers are undertaking initiatives for the development of simpler minimally- and non-invasive hemodynamic monitoring systems at affordable prices, which will offer more precise results. Other factors, rising healthcare expenditure by both government and private sectors and technological advancements, are further expected to create a positive outlook for the market in the coming years.
Key Market Segmentation:
The report provides an analysis of the key trends in each sub-segment of the global hemodynamic monitoring market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, monitoring and end-user.Breakup by Product:
DisposablesMonitors
Others
Breakup by Monitoring:
Invasive MonitoringMinimally Invasive Monitoring
Noninvasive Monitoring
Breakup by End-User:
HospitalsClinics and Ambulatory Care Centers
Home Care Settings
Others
Breakup by Region:
North AmericaUnited States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Edwards Lifesciences Corporation, Lidco Group PLC, Deltex Medical Group PLC, Pulsion Medical Systems SE, GE Healthcare, Osypka Medical GmbH, Tensys Medical, Teleflex Incorporated, ICU Medical Inc., Argon Medical, Schwarzer Cardiotek GmbH, etc.Key Questions Answered in This Report:
How has the global hemodynamic monitoring market performed so far and how will it perform in the coming years?What are the key regional markets?
What has been the impact of COVID-19 on the global hemodynamic monitoring market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the monitoring?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hemodynamic monitoring industry and who are the key players?
What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Hemodynamic Monitoring Market
6 Market Breakup by Product
7 Market Breakup by Monitoring
8 Market Breakup by End-User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Edwards Lifesciences Corporation
- Lidco Group PLC
- Deltex Medical Group PLC
- Pulsion Medical Systems SE
- GE Healthcare
- Osypka Medical GmbH
- Tensys Medical
- Teleflex Incorporated
- ICU Medical Inc.
- Argon Medical
- Schwarzer Cardiotek GmbH
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | July 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 1.15 Billion |
| Forecasted Market Value ( USD | $ 1.68 Billion |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
